| Shareholder Activism

Gilead Capital LP: Insights about commercially available wireless dosimeter 

Excerpts from the letters

Next-Generation Wireless Dosimetry (2010-present): Though Landauer has publicly discussed its plans to develop and launch wireless dosimetry technology since 2010,11 its primary competitor, Mirion, was the first to market with a commercially available wireless dosimeter.12 Landauer’s as-of-yet unreleased product, Verifii, remains an unfulfilled promise. If you are interested to read insights like this, we are happy to offer you a free trial.

Letter